







































Timeline of pain before dementia diagnosis: a
27-year follow-up study
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Mika Kivimäkic,d, Archana Singh-Manouxa,c, Séverine Sabiaa,c,*
Abstract
This study examines the importance of length of follow-up on the association between pain and incident dementia. Further objective
was to characterize pain trajectories in the 27 years preceding dementia diagnosis and compare them with those among persons
free of dementia during the same period. Pain intensity and pain interference (averaged as total pain) weremeasured on 9 occasions
(1991-2016) using the Short-Form 36 Questionnaire amongst 9046 (women5 31.4%) dementia-free adults aged 40 to 64 years in
1991; 567 dementia cases were recorded between 1991 and 2019. Cox regression was used to assess the association between
pain measures at different time points and incident dementia and mixed models to assess pain trajectories preceding dementia
diagnosis or end point for dementia-free participants. Results from Cox regression showed moderate/severe compared with mild/
no total pain, pain intensity, and pain interference not to be associatedwith dementia when themean follow-upwas 25.0, 19.6, 14.5,
or 10.0 years. These associations were evident for amean follow-up of 6.2 years: for total pain (hazard ratio5 1.72; 95% confidence
intervals 5 1.28-2.33), pain intensity (1.41; 1.04-1.92), and pain interference (1.80; 1.30-2.49). These associations were stronger
when the mean follow-up for incidence of dementia was 3.2 years. Twenty-seven–year pain trajectories differed between dementia
cases and noncases with small differences in total pain and pain interference evident 16 years before dementia diagnosis (difference
in the total pain score 5 1.4, 95% confidence intervals 5 0.1-2.7) and rapidly increasing closer to diagnosis. In conclusion, these
findings suggest that pain is a correlate or prodromal symptom rather than a cause of dementia.
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1. Introduction
Permanent structural changes in brains of those with chronic
pain2,7,11,25 resemble that seen in neurodegenerative diseases
such as dementia.3 Pain dimensions, namely sensory-
discriminative, cognitive-evaluative, and affective motivational,
are known to activate a wide network of brain regions.13,19 It is
likely that there is an overlap in structural brain changes in chronic
pain and dementia. Chronic pain affects cognitive, mood, and
mental status6,10 and is also a feature of dementia.8,12 However,
the long-term association between pain and dementia remains
unclear; pain could be a cause, correlate, or a prodromal feature
of dementia.
Associations of pain or painful chronic conditionswith cognitive
decline5,20–22,28,29 and dementia have been documented in
several studies9,15,27,33,36,37,39; however, few studies have
examined the temporal nature of this association, and the
evidence is inconsistent. Most aforementioned studies were
conducted amongst older populations and had less than 5-year
mean follow-up. Given that dementia is characterized by a
preclinical period lasting 15 to 20 years,24 it is possible that
previous findings were affected by reverse causation whereby the
observed association is primarily due to increase in pain in the
preclinical period of dementia.
Accordingly, our objective was to examine the temporal
association between pain scores, composed of pain interference
and pain intensity, and incident dementia using time-to-event
analysis with mean duration between pain assessment and
dementia diagnosis varying from 25 to 3.2 years. Complemen-
tarily, we characterized pain trajectories, in almost 3 decades
preceding dementia diagnosis and compared them with those
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questionnaires on health behaviors, physical and mental well-
being every 2 to 3 years, and clinical examinations including
anthropometric measures and health-related parameters every 4
to 5 years until the most recent examination in 2015 to 2016.
Participants’ written, informed consent and research ethics
approval are renewed at each contact; the most recent approval
was from the National Health Service London—Harrow Research
Ethics Committee, reference number 85/0938.
2.2. Pain
Pain was assessed using the “bodily pain scale” of the Short-
Form 36 (SF-36) questionnaire on 9 occasions since its
introduction to the study in 1991 to 1993 (in 1995, 1997-1999,
2001, 2002-2004, 2006, 2007-2009, 2012-2013, and 2015-
2016). SF-36 assesses quality of life based on 8 scales35 (vitality,
physical functioning, bodily pain, general health, physical role
functioning, emotional role functioning, social role functioning,
and mental health) of which the bodily pain scale has been used
for assessment of pain in previous studies.9 The bodily pain scale
is composed of 2 questions that assess pain intensity and pain
interference “over the past 4 weeks.” Intensity measurement
ranges from none (scored 100), very mild (scored 80), mild
(scored 60), moderate (scored 40), severe (scored 20) to very
severe (scored 0). Similarly, interference measurement ranges
from not at all (scored 100), a little bit (scored 75), moderately
(scored 50), quite a bit (scored 25) up to extremely (scored 0).
Total pain is calculated by averaging the pain intensity and
interference scores. To ease interpretation, the usual scoring was
reversed such that higher scores on pain intensity, pain
interference, and total pain indicated higher pain levels. The
following 3 continuous pain measures were used: “total pain,”
“pain intensity,” and “pain interference.” We also categorized
these measures into 2 groups: “moderate to severe” and “mild or
no” pain.
2.3. Incidence of dementia
Dementia was ascertained by linkage to 3 electronic health
records: Hospital Episode Statistics, Mental Health Services Data
Set, and mortality register up to the March 31, 2019, using a
unique National Health Service identifier for each individual.
Dementia cases were identified based on ICD-10 codes F00,
F01, F02, F03, F05.1, G30, G31.0, G31.1, and G31.8 (Table S1,
http://links.lww.com/PAIN/B185); the date of diagnosis was set
at the first record of disease in these databases. The sensitivity
and specificity of dementia diagnosis in Hospital Episode
Statistics data has been reported to be 78.0% and 92.0%.26
Additional use of Mental Health Services Data Set in our study is
likely to improve sensitivity of dementia diagnosis.38
2.4. Covariates
Sociodemographic factors included age, birth cohort (in 5 year
bands), sex, ethnicity (white and nonwhite), education (less than
primary school, lower secondary school, higher secondary
school, university, and higher university degree), and marital
status (married/cohabiting and others) at the time of pain
evaluation. Questionnaire data, electronic health records, or
clinical examinations over the follow-up were used for the
following health conditions: (1) a multimorbidity index comprising
coronary heart disease, stroke, chronic obstructive pulmonary
disease, cancers (except nonmelanoma skin cancers), type 2
diabetes, osteoarthritis and rheumatoid arthritis, Parkinson
disease, and obesity (based on the body mass index $ 30
kg/m2); (2) depression based on electronic health records and
use of antidepressants; and (3) pain medication based on use of
analgesic and antirheumatic medications.
2.5. Statistical analysis
Characteristics of the study population as a function of dementia
status at the end of the follow-up were compared using Pearson
x2 and analysis of variance tests. Then 2 sets of analysis were
performed, as described below.
2.5.1. Time-to-event analysis
We used Cox regression to assess the association between
pain (separately for continuous and dichotomised scores)
measured in 1991 to 1993 wave and incident dementia. These
analyses were repeated with pain measurements drawn from
waves 1997 to 1999, 2003 to 2004, 2008 to 2009, 2012 to
2013, and 2015 to 2016 to assess whether the length of the
follow-up had an impact on observed associations. Participants
were censored at dementia diagnosis, death, or March 31,
2019, whichever came first. Age was used as the timescale, and
analysis was stratified on birth cohort and initially adjusted for
sex, ethnicity, marital status, and education (model 1), then also
for multimorbidity index, depression, and painmedication use at
the time of pain measurement (model 2). Analyses were
undertaken using pain as a continuous (10-point increase)
and a dichotomousmeasure (“moderate to severe” pain vs “mild
or no pain”).
2.5.2. Retrospective analysis of 27-year pain trajectories
This analysis aimed at comparing individual pain trajectories in
dementia cases with noncases among the study population. We
used mixed linear models with continuous pain variables as the
dependent variables and a backward timescale, such that index
date (date of dementia diagnosis for cases and the earliest of
March 31, 2019, or date of death for noncases) was year 0, and
pain measures were modeled from year 0 to year 227. Similar
analyses were undertaken for dichotomized pain measures
(“moderate to severe” vs “mild or no” pain) using mixed logistic
models. Mixed models have the advantage to use all available
data over the follow-up, handle differences in length of follow-up,
and account for the correlation of the repeated measures on the
same individual. Cubic spline regression curves based on mixed
models suggested the use of time, time2, and time3 terms (slope
terms) to model nonlinear changes in pain trajectories (see
Figures S1 and S2 in the supplement, available at http://links.
lww.com/PAIN/B185). Random effects for the intercept and time
allowed individual differences in the pain score at intercept (year
0) and change in pain over time. Analyseswere adjusted for age at
year 0, sex, education, ethnicity, marital status, dementia status,
the terms for slope, interaction between these covariates and the
terms for slope, and for birth cohort (model 1). The analyses were
then also adjusted for pain medication use, multimorbidity index,
and depression at the time of pain measurement (model 2). The
beta associated with the dementia term yielded the difference in
pain at year 0 between dementia cases and noncases. The
interaction term between dementia and slope terms denoted
whether change in pain over the previous 27 years differed by
dementia status. The differences in pain between cases and
noncases for each of the 27 years of the follow-upwere estimated
using the MARGINS commands in STATA. All analyses were
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performed using STATA 15.1(64-bit). All resulting P-values were
two-tailed, and a P value # 0.05 was considered significant.
3. Results
3.1. Study population characteristics
Of the 10308 participants at study inception (1985-1988), 9284
had participated in at least one of thewaves between 1991 to 1993
and 2015 to 2016 amongwhom238 participants hadmissing data
on pain or covariates, leaving a study population of 9046 (2840
women and 6206 men) participants (flowchart in Figure S3 in the
supplement, available at http://links.lww.com/PAIN/B185). Com-
pared with excluded study participants, those included were more
likely to be younger (included vs excluded participantsmean age of
44.8 vs 45.7 years in 1985;P, 0.001),men (68.6% vs 54.6%;P,
0.001), white (90.7% vs 77.5%, P , 0.001), married/cohabiting
(75.0% vs 67.1%; P , 0.001), and to have university education
(27.1% vs 17.1%; P , 0.001) (Table S2 in the supplement,
available at http://links.lww.com/PAIN/B185).
Amongst the 9046 study participants, 567developeddementia at
the mean age of 77.0 (SD 5 5.9) years over the mean 25 years of
follow-up, and 56.1% of these cases were diagnosed in the last 5
years of follow-up. Table 1 shows that dementia cases were more
likely to be older (mean age 5 55.8 vs 50.3 years, P , 0.001),
women (39.5% vs 30.9%, P, 0.001), less likely to be white (86.4%
vs 91.0%, P , 0.001), to have university education (21.0% vs
27.5%,P, 0.001), and presentedmore oftenwith chronic diseases
(23.8% vs 15.9%, P , 0.001) and depression (4.8% vs 3.1%, P 5
0.03). Dementia cases also had higher mean pain scores at first
wave of pain measurement (19.4 vs 15.7 for total pain, P , 0.001)
which became larger at the last wave of pain measurement
(Table 1). On average, 6.9 pain measures were recorded in
noncases and 5.8 in dementia cases. There was no evidence of sex
differences in associations of pain with dementia (Pinteraction . 0.07)
leading us to combine both sexes in the analysis.
3.2. Association between pain and incident dementia
Table 2 shows results from Cox regression for the associations of
continuous and dichotomized pain score measures recorded at
1991 to 1993, 1997 to 1999, 2003 to 2004, 2007 to 2009, 2012 to
2013, and 2015 to 2016 waves with incident dementia, using a
mean follow-up of 25.0, 19.6, 14.5, 10.0, 6.2, and 3.2 years,
respectively. In analysis not adjusted for health conditions (model
1), the continuous pain interference was associated with increased
hazard ratio (HR) of dementia, irrespective of the length of the
follow-up (time between pain assessment and date of dementia
diagnosis or end of follow-up for noncases). In the fully adjusted
analyses (model 2), the association remained only when the mean
follow-up was 10 years (HR per 10-point increase5 1.06; 95% CI
[confidence intervals]: 1.01-1.11;P5 0.03) or less. The association
between the dichotomized pain measures and dementia strength-
ened as the follow-up became shorter; when mean follow-up was
3.2 years, total pain (HR 5 2.17; 95% CI: 1.40-3.38; P 5 0.001),
pain intensity (HR 5 1.59; 95% CI: 1.01-2.50; P 5 0.05), and
interference (HR 5 2.57; 95% CI: 1.61-4.09; P , 0.001) were all
associated with dementia in fully adjusted analyses.
3.3. Pain trajectories over 27 years of follow-up
Pain trajectories over the 27-year follow-up differed between
dementia cases and noncases (Figure 1 for fully adjusted model,
and Figure S4 for model 1, http://links.lww.com/PAIN/B185) as
shown by significant interaction between dementia status and
slope terms for total pain (Pinteraction 5 0.004) and pain
interference (Pinteraction, 0.001). In fully adjusted analyses (model
2, Table 3; corresponding results for Model 1 in Table S3, http://
links.lww.com/PAIN/B185), dementia cases had higher total pain
scores than noncases starting 16 years before diagnosis
(difference 5 1.4, 95% CI: 0.1-2.7; P 5 0.04, corresponding to
7% of an SD of the total pain score). Difference in the pain score
increased steadily to reach 5.5 (95% CI: 2.5-8.4; P , 0.001) at
dementia diagnosis (year 0), corresponding to 28% of SD of the
total pain score. These differences were driven primarily by the
pain interference component, where differences between cases
and noncases began at year 216 and increased to reach 8.0
(95% CI: 4.8-11.2; P , 0.001) at dementia diagnosis (year 0).
Differences in pain intensity were confined to the 7 years before
Table 1
Characteristics of participants as a function of dementia
status at the end of follow-up* (March 31, 2019).
No dementia Dementia P
N 5 8479 N 5 567
n % n %
Women 2616 30.9 224 39.5 ,0.001
White 7713 91.0 490 86.4 ,0.001
University-level education 2329 27.5 119 21.0 ,0.001
n % n % P
Characteristics at the first wave of
pain measurement
Married/cohabiting 6480 76.4 412 72.7 0.04
Depression 263 3.1 27 4.8 0.03
Pain medication use 559 6.6 48 8.5 0.08
At least 1 chronic disease† 1345 15.9 135 23.8 ,0.001
Moderate to severe pain
Total pain (score . 32.5) 1125 13.3 104 18.3 0.001
Pain intensity (score . 40) 1272 15.0 120 21.2 ,0.001
Pain interference (score .
25)
686 8.1 74 13.1 ,0.001
Mean SD Mean SD P
Age, y 50.3 6.3 55.8 5.1 ,0.001
Pain variables
Total pain 15.7 19.3 19.4 22.2 ,0.001
Pain intensity 21.9 23.4 25.9 25.5 ,0.001
Pain interference 9.4 18.8 12.9 22.3 ,0.001
n % n % P
Characteristics at last wave of pain
measurement
Married/cohabiting 6017 71.0 363 64.0 ,0.001
Depression 957 11.3 104 18.3 ,0.001
Pain medication use 1453 17.1 116 20.5 0.04
At least 1 chronic disease† 4416 52.1 335 59.1 0.001
Moderate to severe pain
Total pain (score . 32.5) 2119 25.0 228 40.2 ,0.001
Pain intensity (score . 40) 2160 25.5 209 36.9 ,0.001
Pain interference (score .
25)
1472 17.4 182 32.1 ,0.001
Mean SD Mean SD P
Age, y 68.9 8.6 70.9 8.1 ,0.001
Pain variables
Total pain 24.2 22.7 31.2 26.7 ,0.001
Pain intensity 31.2 24.5 35.6 27.3 ,0.001
Pain interference 17.3 24.1 26.7 29.1 ,0.001
* Among participants with data at least once over the follow-up period.
† Chronic diseases: coronary heart disease, stroke, chronic obstructive pulmonary disease, cancers, type 2
diabetes, osteoarthritis, rheumatoid arthritis, Parkinson disease, and obesity.
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Table 2
Association between pain (continuous [10-point increase] and dichotomous measures) and incident dementia: analysis using
Cox regression.
Total pain Pain intensity Pain interference
N cases/
N total
Model 1* Model 2† N cases/
N total
Model 1* Model 2† N cases/N
Total













Pain in 1991-1993 (mean
follow-up 5 25.0 y, SD 5
4.7)












Moderate to severe pain
No 427/7240 1 Ref. 1 Ref. 410/7057 1 Ref. 1 Ref. 454/7665 1 Ref. 1 Ref.












Pain in 1997-1999 (mean
follow-up 5 19.6 y,
SD 5 3.8)












Moderate to severe pain
No 334/5879 1 Ref. 1 Ref. 327/5814 1 Ref. 1 Ref. 357/6300 1 Ref. 1 Ref.












Pain in 2002-2004 (mean
follow-up 5 14.5 y,
SD 5 2.9)












Moderate to severe pain
No 291/5434 1 Ref. 1 Ref. 291/5317 1 Ref. 1 Ref. 324/5939 1 Ref. 1 Ref.












Pain in 2007-2009 (mean
follow-up 5 10.0 y,
SD 5 2.0)












Moderate to severe pain
No 233/5223 1 Ref. 1 Ref. 240/5157 1 Ref. 1 Ref. 258/5742 1 Ref. 1 Ref.












Pain in 2012-2013 (Mean
follow-up5 6.2 y, SD5 1.1)












Moderate to severe pain
No 140/4751 1 Ref. 1 Ref. 149/4720 1 Ref. 1 Ref. 162/5224 1 Ref. 1 Ref.












Pain in 2015-2016 (mean
follow-up5 3.2 y, SD5 0.6)












Moderate to severe pain
No 55/4082 1 Ref. 1 Ref. 61/4041 1 Ref. 1 Ref. 63/4521 1 Ref. 1 Ref.












* Model 1: adjusted for age (as timescale), sex, birth cohort, education, ethnicity, and marital status.
† Model 2: model 1 1 pain medication use, multimorbidity index, and depression assessed at the time of pain measurement.
‡ P , 0.05.
§ P , 0.01.
‖ P , 0.001.
CI, confidence intervals; HR, hazard ratio.
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dementia diagnosis (Table 3). Analyses of 27-year trajectories of
the probability of “moderate to severe” pain in fully adjusted
analyses are shown in Figure S5, estimates shown in Table S4 in
the supplement (available at http://links.lww.com/PAIN/B185).
The difference in estimated probability at 2.5% (95% CI: 0.1%-
4.8%; P 5 0.04) for total pain, 2.7% (95% CI: 0.0%-5.5%; P 5
0.05) for pain intensity, and 1.9% (95%CI: 0.1%-3.7%; P5 0.03)
for pain interference began at year 211, 26, and 212 years,
respectively. At dementia diagnosis, these increased approxi-
mately 5 times for total pain and pain interference (Table S4,
http://links.lww.com/PAIN/B185).
4. Discussion
This longitudinal study with repeated painmeasures collected over
27 years suggests steady progression in self-reported pain before
dementia diagnosis. Time-to-event analysis, where data on pain
measures over the course of the study were used to assess the
impact of the length of follow-up on the association between pain
and incident dementia, showed the association to be evident only
when the mean follow-up was 10 years or lower. The use of
backward pain trajectories describes how small differences in pain
scores between dementia cases and noncases become in-
creasingly pronounced in the decade before diagnosis of de-
mentia. Taken together, these results highlight the time-dependent
association between pain and dementia; given the long preclinical
phaseof dementia, there is no strongevidence fromour results that
pain is a causal risk factor for dementia.
Several previous studies have examined the association
between pain and cognitive outcomes, some5,18,20–22,28–30 but
not all studies20,32 have suggested pain to be associated with
impairment of cognitive domains such as attention, working
Table 3
Differences in the pain score between dementia cases and noncases in the 27 y preceding dementia diagnosis in fully adjusted
analysis.
Years before the index date Total pain P Pain intensity P Pain interference P
Diff 95% CI Diff 95% CI Diff 95% CI
227 20.2 23.2, 2.9 0.90 0.8 22.8, 4.4 0.66 21.1 24.3, 2.1 0.51
226 0.1 22.4, 2.5 0.97 0.9 22.0, 3.8 0.53 20.7 23.3, 1.8 0.57
225 0.3 21.7, 2.3 0.79 1.0 21.3, 3.4 0.39 20.4 22.5, 1.6 0.69
224 0.5 21.2, 2.2 0.60 1.1 20.9, 3.1 0.27 20.1 21.9, 1.6 0.87
223 0.6 20.9, 2.2 0.42 1.2 20.6, 3.0 0.19 0.1 21.4, 1.6 0.90
222 0.8 20.7, 2.2 0.29 1.3 20.4, 3.0 0.15 0.3 21.1, 1.7 0.66
221 0.9 20.5, 2.3 0.21 1.3 20.3, 3.0 0.12 0.5 20.9, 1.9 0.46
220 1.0 20.4, 2.4 0.15 1.3 20.3, 3.0 0.11 0.7 20.7, 2.1 0.31
219 1.1 20.3, 2.5 0.11 1.4 20.2, 3.0 0.10 0.9 20.5, 2.3 0.21
218 1.2 20.1, 2.6 0.08 1.4 20.2, 3.0 0.09 1.1 20.3, 2.4 0.13
217 1.3 20.0, 2.7 0.06 1.4 20.1, 3.0 0.08 1.2 20.1, 2.6 0.07
216 1.4 0.1, 2.7 0.04 1.4 20.1, 2.9 0.07 1.4 0.1, 2.7 0.04
215 1.5 0.2, 2.8 0.02 1.4 20.1, 2.9 0.06 1.6 0.3, 2.9 0.02
214 1.6 0.3, 2.9 0.02 1.4 20.0, 2.9 0.06 1.8 0.5, 3.1 0.008
213 1.7 0.4, 3.0 0.01 1.5 20.0, 3.0 0.06 2.0 0.6, 3.3 0.004
212 1.8 0.5, 3.2 0.007 1.5 20.0, 3.0 0.06 2.2 0.8, 3.5 0.002
211 2.0 0.6, 3.3 0.005 1.5 20.1, 3.1 0.06 2.4 1.0, 3.8 0.001
210 2.1 0.7, 3.5 0.003 1.5 20.1, 3.1 0.06 2.7 1.3, 4.1 ,0.001
29 2.3 0.9, 3.8 0.002 1.6 20.1, 3.2 0.06 3.0 1.5, 4.5 ,0.001
28 2.5 1.0, 4.0 0.001 1.6 0.0, 3.3 0.06 3.3 1.8, 4.9 ,0.001
27 2.8 1.3, 4.3 ,0.001 1.7 0.0, 3.4 0.05 3.7 2.2, 5.3 ,0.001
26 3.0 1.5, 4.5 ,0.001 1.8 0.1, 3.5 0.04 4.2 2.6, 5.7 ,0.001
25 3.3 1.8, 4.9 ,0.001 1.9 0.1, 3.6 0.03 4.7 3.0, 6.3 ,0.001
24 3.7 2.0, 5.3 ,0.001 2.0 0.2, 3.8 0.03 5.2 3.5, 6.9 ,0.001
23 4.0 2.3, 5.8 ,0.001 2.1 0.2, 4.1 0.04 5.8 3.9, 7.6 ,0.001
22 4.5 2.4, 6.5 ,0.001 2.3 0.0, 4.6 0.05 6.5 4.3, 8.6 ,0.001
21 4.9 2.5, 7.4 ,0.001 2.5 20.3, 5.3 0.08 7.2 4.6, 9.8 ,0.001
0 5.5 2.5, 8.4 ,0.001 2.7 20.7, 6.1 0.12 8.0 4.8, 11.2 ,0.001
Difference in trajectories P 5 0.004 P 5 0.84 P , 0.001
Estimates were extracted from linear mixed models adjusted for age at year 0, sex, education, ethnicity, marital status, dementia status, slope terms (time, time2, and time3), and interaction of these covariates with slope terms,
birth cohort, pain medication use, multimorbidity index, and depression assessed at the time of pain measurement.
CI, confidence intervals; Diff, difference.
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memory, psychomotor speed, and executive function. Whitlock
et al.37 reported faster 12-year memory decline and increase in
the dementia probability score among individuals with 2-year
moderate to severe persistent pain. A systematic review and
meta-analysis of longitudinal studies with a follow-up ranging
2.75 to 11.8 years found no association between persistent pain
and incident cognitive decline/dementia, but stratification of
studies based on follow-up period revealed an association when
follow-up was shorter than 4.5 years.1 Cognitive decline has also
been shown to affect pain perception,16 suggesting the need for
closer attention to temporal framework in analysis of pain as a risk
factor for dementia.
Pain9 and chronic painful conditions such as fibromyalgia,27
osteoarthritis,36 and headache33 have been found to be
associated with risk of dementia. Few studies examine both the
associations of pain intensity and pain interference, one such
study with a 4-year mean follow-up found pain interference rather
than intensity to be associated with dementia.9 Other studies
show pain interference, irrespective of the site39 or nature of
painful disease15 to be associated with dementia risk. Our results
also show pain interference rather than pain intensity to be the
driver of observed associations between pain and dementia.
Affective and cognitive domains of pain13 are likely to determine
subjective experience of pain interference.4 These pain domains
are affected early in dementia-related neurodegeneration,23
underlying the emergence of pain interference in the preclinical
phase of dementia. In agreement, the association between pain
interference and incident dementia was observed earlier than the
association between pain intensity and dementia in this study.
Nonetheless, the association needs to be interpretedwith caution
because limitations in daily activities, irrespective of pain, emerge
in the decade preceding diagnosis.31 Some authors suggest pain
interference and limitations in daily activities as distinct do-
mains17; thus, increase in pain interference and limitations in daily
activities might be 2 different features observed in the dementia
preclinical period.
To the best of our knowledge, this is the first study to
investigate the role of time in the association between pain and
dementia. An important feature of this analysis is the construction
of retrospective backward trajectories of pain spanning 27 years
before dementia diagnosis allowing progressive change in pain to
be tracked. Most previous studies used a mean follow-up of less
than 5 years with pain assessed only at baseline, ignoring the time
varying nature of pain. Our study, by combining findings from
both backward trajectories and Cox regression models repeated
at varying time points with mean follow-up ranging from 3 to 25
years, permits a more comprehensive analysis of the timeline of
the association between pain and dementia in its preclinical
phase.
There are several possible explanations for the observed
progression of pain before dementia diagnosis. One, pain could
be a causal risk factor for dementia. Chronic pain–induced
chronic stress14 through cortisol dysfunction14 and neuroglial
inflammation14,20 can disrupt neuronal environment, accelerating
neurodegenerative processes. However, differences in pain
scores observed 16 years before dementia diagnoses between
dementia cases and noncases in the backward trajectory models
were negligible (around 1.4) when compared with the minimal
clinically important difference of 4.9 suggested for rheumatoid
arthritis.34 Cox regression adjusted only for sociodemographic
factors showed an association between pain interference and
incidence of dementia, but further adjustment for health
conditions attenuated associations except when the time
between pain measures and dementia diagnosis was 10 years
or less. These findings suggest that pain is not an independent,
causal risk factor for dementia. Two, pain could be a preclinical
symptom of dementia. Brain structures involved in motivational-
affective and cognitive-evaluative pain processing are affected
early in dementia-related neurodegeneration,12,23 underpinning
the longer-term association between pain interference and
dementia. Three, pain and dementia may have common causes
as both share pathophysiological mechanisms within the brain.3
Figure 1. Twenty-seven–year trajectories of pain, using continuous measures, before dementia diagnosis. Noncase; case. Estimated from linear
mixed models adjusted for age at year 0, sex, education, ethnicity, marital status, dementia status, slope terms (time, time2, and time3), interaction of these
covariates with slope terms, birth cohort, pain medication use, multimorbidity index, and depression assessed at the time of pain measurement. Estimates came
from Margins command in STATA. Higher scores correspond to higher pain.
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Limitations of this study include lack of data on the
characteristics, type, and location of pain. The specific chronic
conditions that contributed to the association between pain and
dementia could not be examined in sufficient detail. Our multi-
morbidity index included a range of conditions to reflect overall
disease burden; it is possible that some of these play a more
important role than others. Finally, as dementia diagnosis was
based on electronic health records, we did not have complete
information on type or severity of dementia. This method might
miss milder dementia, but it has the advantage of providing data
on dementia for all participants recruited to the study rather than
those who consent to face-to-face assessment of dementia
status over the follow-up.
5. Conclusion
Dementia is a major challenge for social and health care because
of aging of populations, highlighting the need to better un-
derstand the course of dementia, associated symptoms, and risk
factors for effective preventive strategies. We found pain to
increase rapidly in the preclinical period of dementia such that
association of pain with dementia became stronger when
assessed closer in time to dementia diagnosis. These findings
suggest that pain is a prodromal symptom of dementia or both
share common causal mechanisms rather than an important
contributor to risk of dementia. Between pain intensity and pain
interference, it was the latter that had a stronger association with
dementia highlighting the need for better management of pain in
older adults.
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